Don’t Be Surprised to See Semaglutide for Kidney Disease
October 2024
You may start to get more semaglutide Rxs for patients with chronic kidney disease (CKD) and diabetes.
That’s because a new study in patients with type 2 diabetes and CKD shows that injectable semaglutide (Ozempic) 1 mg weekly for 3 years reduces the risk of kidney failure and worsening kidney function.
But patients with type 2 diabetes should still follow a stepwise approach to help slow CKD progression.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote